NEW YORK (GenomeWeb News) – WaferGen today reported that its first-quarter revenues tripled and its net loss nearly doubled for the three-month period ended March 31.
 
The Fremont, Calif.-based firm also announced that it has signed two private placements that could bring in close to $6 million in funding.
 
WaferGen, which makes the SmartChip Real-Time PCR System, brought in Q1 revenues of $181,640, compared to 2007 first-quarter revenues of $60,460.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.